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A B S T R A C T
Post-traumatic stress disorder (PTSD) arises after an individual has experienced a major traumatic event. Recent
evidence suggests that acute morphine treatment may serve as a strategy to reduce PTSD development. In the
present study, we investigated the time-dependent effects of morphine on behavioral and morphological deficits
induced by the single prolonged stress (SPS), an experimental model of PTSD, in adult male rats. The rats were
exposed to SPS (restraint for 2 h, forced swimming for 20min, and ether anesthesia), and kept undistributed for
11 days. Morphine was injected immediately, 6, 12 and 24 h after SPS. Anxiety profile was evaluated using the
elevated plus maze11 days after SPS. Then, animals were conditioned in a fear conditioning task and extinction
training was performed on days 1, 2, 3, 4 and 11 after fear conditioning which followed by morphological
assessments in the medial prefrontal cortex (mPFC). SPS rats showed increased anxiety levels and impaired
contextual fear extinction retention. SPS also decreased dendritic length in the infra-limbic (IL) and dendritic
spines in the IL and pre-limbic (PL) regions of the mPFC. Conversely, morphine treatment 6, 12 and 24 h but not
immediately after SPS significantly improved anxiety-like behaviors, fear extinction, increased dendritic length,
and spines in the mPFC. Morphine-induced much stronger response when injected 24 h after the SPS, and this
effect was blocked by naloxone. Our findings show that morphine within a restricted time window selectively
reversed the SPS-induced deficits in anxiety profile, fear extinction, and dendritic morphology in the mPFC.
Finally, these findings suggest that the time point of morphine injection following a traumatic event is an im-
portant determinant of the full therapeutic effect of morphine against PTSD.
1. Introduction
Most of the people experience, at least, one tremendous traumatic
event throughout their lives [1,2]. Fortunately, most of them will forget
about the traumatic event after a while [3]. Although more than half of
these traumatic events such as war, rape, burn and dangerous car ac-
cident are very fearful by nature [4,5], a small but significant minority
of people go through post-traumatic stress disorder (PTSD) [3,4,6].
PTSD arises after an awful traumatic experience [7] and according to
the 5th edition of the diagnostic and statistical manual (DSM-5), char-
acterized by continuous re-experience of the traumatic event, avoid-
ance of trauma associated stimuli, negative affect emotional numbing
and hyperarousal [8]. All these symptoms should be last for at least one
month and cause serious problems in daily life activity [8]. Moreover,
PTSD patients often experience a flashback of the events and general
anxiety.
Given to wrecking trait of PTSD and because of lack of effective
available treatment for patients whose disease has been diagnosed with
PTSD, many researchers have been targeted at the early pharmacolo-
gical interventions immediately after traumatic events. The data sug-
gest that some medications such as propranolol [9], hydrocortisone
[10] and oxytocin [11] soon after traumatic events may protect in-
dividuals against PTSD or reduce the severity of their symptoms
[12,13].
Recent evidence has shown that acute morphine treatment may
serve as a strategy to reduce PTSD development [14]. Some clinical
studies have shown that acute morphine administration within hours of
injury leads to a significant lower PTSD prevalence and mood disorders
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[15,16]. The data have been gathered after the Iraq war showed that
use of morphine during early trauma care leads to lower risk of PTSD
[16]. Again, morphine treatment after the single traumatic event and
burn was associated with a reduced risk of the PTSD in children
[17,18]. These clinical studies suggest that morphine treatment after a
traumatic event may be associated with a lower probability of the
PTSD; however, such a claim is largely difficult in the case of the
human. On the other hand, some studies have investigated the inter-
action between morphine and PTSD in the experimental models of
PTSD [19,20]. Long-term memory formation, which lasts from several
hours to several days and even more, needs a remarkable consolidation
process, which takes several hours [21]. It has been reported that
opioids may negatively modulate memories during this important time
[22,23]. Moreover, morphine impairs long-term acquisition in con-
textual fear conditioning (CFC), and radial and Morris water maze
[24,25]. A recent study has shown that repeated morphine adminis-
tration after the severe stressor or single injection of morphine at 48 h
after the severe stressor prevents the development of stress - enhanced
fear learning [20]. Altogether, these studies emphasize the protective
effects of morphine on PTSD but the time window of morphine ad-
ministration has not been precisely defined.
A large body of literature shows that PTSD might be associated with
extinction deficits [26,27]. Fear extinction is a form of learning and
occurs when the fearful conditioned stimulus (CS) no longer leads to a
fear response [28,29]. Fear extinction deficits were precisely in-
vestigated with the single prolonged stress (SPS), which is one of the
privileged animal models of PTSD [30,31]. SPS animals show beha-
vioral and neurobiological hallmarks of PTSD [32] and increased
arousal [31,33]. It has been reported an enhanced fast negative feed-
back of the hypothalamic-pituitary-adrenal (HPA) in SPS rats [30]. SPS
rats show extinction retention deficits like PTSD patients [30,34]. SPS
causes remarkable morphological changes in the amygdala, medial
prefrontal cortex (mPFC) and hippocampus, the main brain regions
critical for extinction retention, which may be involved in the patho-
genesis of PTSD [35,36].
In the present study, we investigated the time-dependent effects of
morphine on anxiety and fear extinction impairment and morphological
deficits in the mPFC induced by SPS, as an experimental model of PTSD
in adult male rats.
2. Materials and methods
2.1. Experimental animal and housing condition
Adult male Wistar rats (200–250 g) were obtained from the
breeding colony of the Semnan University of Medical Sciences (SUMS),
Semnan, Iran. The animals were housed in groups of five and main-
tained in a room with 12-h light, 12-h dark cycle (lights on at 6:00 am),
standard temperature (24 ± 2 °C) and humidity (50 ± 5%). Rats were
given ad libitum access to water and food. The Ethical Review Board of
SUMS (IRSEMUMS.REC.1394.117) approved the experimental protocol
of this study. All experimental procedures followed the guidelines of the
National Institutes of Health Guide for the Care and Use of Laboratory
Animals.
2.2. Drugs
Morphine sulfate and naloxone hydrochloride were purchased from
Sigma (St. Louis, Mo, USA). Both drugs were freshly prepared before
the experiments, dissolved in sterile 0.9 NaCl and administered in-
traperitoneally (i.p.).The doses of morphine (10mg/kg/2 ml) and na-
loxone (1mg/kg/2ml) were chosen based on earlier researches
[19,37].
2.3. SPS model
The SPS model of PTSD consists of three distinct stresses, including
the restraint for 2 h, forced swim for 20min and ether anesthesia
[30,38]. Each rat was placed inside a clear polyethylene cylinder rat
restrainer for 2 h. The restrainers were quite the size of each animal to
achieve complete immobilization. Several holes in the restrainers
caused the rats to breathe freely. This phase followed by 20min forced
swimming in a clear acrylic cylindrical tank (20× 20×50 cm) filled
two-thirds with 24 °C clean water. Animals recuperate for 15min and
then were exposed to ether vapor for 2–3min, until loss of conscious-
ness. Finally, animals were returned to their home cage and left un-
disturbed for 11 days.
2.4. Anxiety test in the Elevated plus maze
The elevated plus maze (EPM) is a valid tool to measure anxiety
profile in the rats [39]. The EPM consisted of a plus-shaped and wooden
four arm platform that was painted with gray enamel. Two open arms
(50×10 cm) facing each other were bounded by a 0.5 cm edge to avoid
animals falling and two enclosed arms (50×10 cm, surrounded by 40-
cm high wooden walls) arranged perpendicular to the open arms. The
walls began from a central neutral area (10× 10 cm). All arms were
50 cm elevated above the floor.
At the beginning of each test, animals were gently placed in the
center square always facing one of the open arms and were allowed to
discover the maze for 5min. When the hind limbs of the rats crossed the
arms considered as an entrance. A total number of entries and total time
spent into open arms were used as a measure of anxiety [39]. Anxio-
genic influences selectively decrease the open arm entry and/or open
arm time and, in contrast, anxiolytic influences selectively increase the
open arm entry and/or open arm time. The number of total arm entries
was used as a measure of spontaneous locomotor activity.
2.5. Contextual fear conditioning and extinction
In order to study contextual fear conditioning (CFC) in the rats, an
automated rodent fear conditioning system (TSE, Bad Homburg,
Germany) was used. CFC was performed in a conditioning box as before
described [40]. The conditioning box was made of clear Plexiglas,
which its floor was constructed of 25 stainless steel rods (6 mm in
diameter, 12mm apart) to deliver foot shock. On day zero (fear con-
ditioning session), the rats were placed on the conditioning chamber for
3min and then received 3 foot-shocks (1 mA, 2 s duration) with 40 s
intervals. The animals remained an additional minute in the chamber
before being returned to their home cages. A continuous background
noise and light illumination were provided during this session. The
chamber was cleaned with 5% ethanol after each session.
Extinction training was performed on days 1, 2, 3, 4 and 11 after
fear conditioning. During extinction training, the animals were placed
in the same chamber with the same conditions for 5min, but they did
not get any shock. A trained technician looked at the rats every five
seconds and marked on a sheet if there was freezing. Freezing means
the complete immobility of the rats in a stereotyped crouching position
except for movements necessary for respiration [41]. The extinction
index is the percentage of freezing reduction from the first to the last
extinction day and was calculated with the following formula: the
freezing level during the first extinction day - the last extinction day/
the freezing levels in the first extinction day multiplied by 100.
2.6. Morphological analysis
Golgi-Cox is the most reliable method in determining dendritic ar-
borization [42]. After the completion of the tests, 6 animals of each
group were randomly selected, deeply anesthetized with carbon dioxide
and rapidly decapitated. The brains were gently removed and placed in
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20mL Golgi–Cox solution (potassium dichromate, mercuric chloride
and potassium chromate), where they were stored in the dark for 14
days, and then transferred to a 30% sucrose solution for at least three
days [43]. Coronal 200 μm sections were obtained using a vibratome
collected onto gelatin-coated slides and dehydrated through a graded
series of ethanol, cleared in xylene and coverslipped. An experimenter
visualized individual neurons at 100× using camera lucida. Pyramidal
neurons of the mPFC were selected on the basis of the following criteria:
(1) the cell type must be identical; (2) neurons must be dark and con-
sistently sliver impregnated throughout the extent of all dendrites; (3)
dendrites must be untruncated; and (4) stained neurons must be rela-
tively free from the neighboring impregnated neurons. Pyramidal
neurons were defined by the presence of a basilar dendritic tree, a
distinct, single apical dendrite, and dendritic branch points [44,45]. For
each animal, an average apical dendritic length and branch points
within a 100-μm thick section of each dendritic tree of 6–8 selected
pyramidal neurons was calculated. From each experimental group, six
animals randomly were selected for morphology analysis.
2.7. Experimental groups
In order to determine the time window of acute morphine treat-
ment, morphine was injected immediately (0), 6, 12, and 24 h after SPS.
Sham groups were injected with saline in the same way. For each time
point, animals were divided into 4 groups (n=10 in each group):
Sham+Saline, Sham+Morphine, SPS+ Saline and SPS+Morphine.
The SPS animals were left 10 days after SPS to develop symptoms of
PTSD. Sham groups were left undisturbed in their home cages. Anxiety-
like behaviors were assessed on day 11 after SPS with the EPM. Two
weeks after SPS, fear conditioning and extinction training were per-
formed as described earlier (Fig. 1).
To confirm the specificity of the protective effects of morphine on
SPS animals, two additional groups were as used to test whether na-
loxone could prevent the therapeutic effects of morphine administrated
24 h after SPS. Naloxone was injected 30min before saline (n= 10) or
morphine (n= 10) injections and SPS animals were tested according to
procedures described the above.
2.8. Statistical analysis
All data were expressed as a means ± SEM. The results were ana-
lyzed by one-way, or two-way (ANOVA) followed by Bonferroni’s post
hoc test, when appropriate. A p < 0.05 was considered significant.
3. Results
3.1. Anxiety profile
EPM data are shown in Fig. 2. A two-way ANOVA on open arms
time (OAT) demonstrated a significant effect of SPS (F1,144 = 37.422,
P < 0.001) but not the treatment (F7,144 = 1.635, P=0.130), and an
interaction between SPS and treatment (F7,144 = 7.731, P < 0.001).
Between groups comparisons revealed that OAT was significantly de-
creased in the SPS+ Saline 0 h than the Sham+Saline 0 h (P < 0.05),
SPS+ Saline 6 h than the Sham+Saline 6 h (P < 0.05), SPS+ Saline
12 h than the Sham+Saline 12 h (P < 0.01) and SPS+ Saline 24 h
than the Sham+Saline 24 h (P < 0.01) groups. Moreover, OAT was
significantly increased in the SPS+Morphine 12 h than the SPS+
Saline 12 h, and SPS+Morphine 24 h than the SPS+ Saline 24 h (both,
P < 0.05) groups.
A two-way ANOVA on open arms entry (OAE) showed significant
effects of SPS (F1,144 = 12.483, P < 0.01), treatment (F7,144 = 2.682,
P < 0.05) and an interaction between SPS and treatment (F7,144 =
8.796, P < 0.001). Between groups comparisons revealed that OAE
was significantly decreased in the SPS+ Saline 6 h than the
Sham+Saline 6 h (P < 0.01) and SPS+ Saline 24 h than the
Sham+Saline 24 h (P < 0.01). OAE was significantly increased in the
SPS+Morphine 6 h than the SPS+ Saline 6 h (P < 0.01),
SPS+Morphine 12 h than the SPS+ Saline 12 h (P < 0.01), and
SPS+Morphine 24 h than the SPS+ Saline 24 h (P < 0.001).
A two-way ANOVA on total arms entry (TAE) demonstrated no
significant effects of SPS (F1,144 = 3.091, P=0.081) or treatment
(F7,144= 1.654, P=0.125).
These results demonstrated that SPS increased anxiety-like beha-
viors in rats, which blocked by morphine administration, particularly
24 h after the SPS.
3.2. Contextual fear conditioning and extinction
Extinction data are shown in Fig. 3A-D. A one-way ANOVA analysis
on freezing scores during the initial 3 min period (data not shown) in
the conditioning chamber before the presentation of the first foot shock
showed no significant differences among the groups (F17,164 = 0.194,
P > 0.05), which shows no differences in novelty-induced exploratory
behavior between sham and SPS rats. Also, the analysis of the freezing
scores during one min (data not shown) after the last foot shock, a
measure of the acquisition of contextual fear conditioning, demon-
strated no significant differences among the groups (F17,164 = 0.473,
P > 0.05), which shows no differences in contextual fear conditioning
acquisition between the SPS and Sham rats.
When morphine was administered immediately after SPS (Fig. 3A),
mixed ANOVA (groups× days (4×5)) revealed main significant ef-
fects of groups (F3,180 = 17.850, P < 0.001) and days (F4,180 =
55.024, P < 0.001) but not an interaction between groups and days
(F12,180 = 1.410, P > 0.05). Post-hoc analysis indicated that percen-
tage of freezing time of the SPS+ Saline 0 h was significantly higher
than the Sham+Saline 0 h in the extinction 4 (P < 0.01) and ex-
tinction 5 (P < 0.05), but no differences were found between the
SPS+Morphine 0 h and the SPS+ Saline 0 h groups. One - way
ANOVA revealed that the extinction occurred across the multiple ex-
tinction tests in the Sham+Saline 0 h group (F4,54 = 20.320,
P < 0.001). Post-hoc analysis indicated significant differences in the
freezing scores of the extinction 1 with the extinction 2 (P < 0.05), and
extinction 3–5 (all, P < 0.001). The differences in the freezing scores
between the extinction 2 and extinction 4 (P < 0.05), and extinction 2
and extinction 5 (P < 0.001) and the extinction 3 and extinction 5
(P < 0.05) were significant (Fig. 3A).
When morphine was administered 6 h after SPS (Fig. 3B), mixed
ANOVA (groups× days (4×5)) revealed main significant effects of
groups (F3,185 = 55.556, P < 0.001), days (F4,185 = 61.223,
P < 0.001) and an interaction between groups and days (F12,185 =
2.381, P < 0.01). Post-hoc analysis indicated that percentage of
freezing time of the SPS+ Saline 6 h was significantly higher than the
Sham+Saline 6 h in the extinction 4 (P < 0.01) and extinction 5
Fig. 1. Timeline of the experiment (see
Martials and Methods for more detail).
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(P < 0.001). The freezing response in the SPS+Morphine 6 h group
was lower than the SPS+ Saline 6 h group in the extinction 5
(P < 0.01). Moreover, to examine the occurrence of extinction across
extinction tests in the Sham+Saline 6 h group, a one-way ANOVA on
the extinction data revealed significant effects of extinctions days
(F4,39= 50.356, P < 0.001). Post-hoc analysis indicated a significant
difference in the percentage of freezing time between the extinction 1
and the extinctions 2–5 (all, P < 0.001) tests. Significant differences in
the freezing scores were also found between the extinction 2 and ex-
tinctions 4–5 (both, P < 0.001), and the extinction 3 and extinction 5
(P < 0.001) sessions (Fig. 3B).
When morphine was administered 12 h after SPS (Fig. 3C), mixed
ANOVA (groups× days (4×5)) revealed main significant effects of
groups (F3,190 = 46.159, P < 0.001), days (F4,190 = 97.518,
P < 0.001) and an interaction between groups and days (F12,190 =
3.193, P < 0.01). Post-hoc analysis indicated that percentage of
freezing time of the SPS+ Saline 12 h was significantly higher than the
Sham+Saline 12 h group in the extinction 3 (P < 0.05), extinction 4
(P < 0.01) and extinction 5 (P < 0.001). The freezing response in the
SPS+Morphine 12 h group was lower than the SPS+ Saline 12 h
Fig. 2. Anxiety-like behaviors were assessed in the EPM. (A) Time spent in open arm, (B) open arm entry and (C) total arm entry as a measure of spontaneous
locomotor activity. In (A); a: P < 0.05 than the Sham+SAL 0 h group; b: P < 0.05 than the Sham+SAL 6 h group; c: P < 0.01 than the Sham+SAL 12 h group;
d: P < 0.01 than the Sham+SAL 24 h group; e: P < 0.05 than the SPS+ SAL 12 h group and f: P < 0.001 than the SPS+ SAL 24 h group. In (B); a: P < 0.01 than
the Sham+SAL 6 h group, b: P < 0.01 than the Sham+SAL 24 h group; c: P < 0.01 than the SPS+ SAL 6 h group, d: P < 0.01 than the SPS+ SAL 12 h group
and e: P < 0.001 than the SPS+ SAL 24 h group. Data represent the mean ± SEM.
Fig. 3. Effects of morphine injection in different time points following the SPS on subsequent contextual fear extinction in sham and SPS animals. In A: a:P < 0.01
and b:P < 0.05 than the Sham+Saline 0 h group. In B: a:P < 0.01 and b:P < 0.05 compared with the Sham+Saline 6 h group. c:P < 0.01 compared with the
SPS+ Saline 6 h animals. In C: a:P < 0.05, b:P < 0.01 and 5 c:P < 0.001 compared with the Sham+Saline 12 h group; d:P < 0.05 and e:P < 0.01 compared
with the SPS+ Saline 12 h animals. In D: a:P < 0.001, b:P < 0.001 and c:P < 0.001 compared with the Sham+Saline 24 h group; d:P < 0.001, e: P < 0.001
and f: P < 0.001 compared with the SPS+ Saline 24 h animals. In E: Extinction index; a:P < 0.01 than the Sham+Saline 0 h group, b:P < 0.01 than the
Sham+Saline 6 h group, c:P < 0.001 than the Sham+Saline 12 h group and d:P < 0.001 than the Sham+Saline 24 h group, e:P < 0.05 than the SPS+ Saline
6 h, f: P < 0.01 than the SPS+ Saline 12 h and g:P < 0.001 than the SPS+ Saline 24 h. Data represent the mean ± SEM. SAL: Saline, MOR: Morphine, SPS: Single
prolonged stress.
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groups in the extinction 4 (P < 0.05) and extinction 5 (P < 0.01). A
one-way ANOVA revealed that extinction occurred across multiple ex-
tinction tests in the Sham+Saline 12 h group (F4,54 = 26.488,
P < 0.001). Post-hoc analysis indicated significant differences in the
percentage of freezing between the extinction 1 and the extinction 2
(P < 0.05), and extinction 3–5 (all, P < 0.001) tests. Significant dif-
ferences also were found between the extinction 2 and extinction 5
(P < 0.001), the extinction 3 and extinction 5 (P < 0.001), and the
extinction 4 and extinction 5 (P < 0.01) tests (Fig.3C).
When morphine was administered 24 h after SPS (Fig. 3D), mixed
ANOVA (groups× days (4×5)) revealed main significant effects of
groups (F3,190 = 30.610, P < 0.001), days (F4,190 = 38.722,
P < 0.001) and an interaction between groups and days (F12,190 =
2.264, P < 0.01). Post-hoc analysis indicated that percentage of
freezing time of the SPS+ Saline 24 h was significantly higher than the
Sham+Saline 24 h in the extinction 3 (P < 0.01), extinction 4
(P < 0.05) and extinction 5 (P < 0.01). The freezing response of the
SPS+Morphine 24 h group was lower than the SPS+ Saline 24 h
groups in the extinction 3 (P < 0.001), extinction 4 (P < 0.001) and
extinction 5 (P < 0.001). An ANOVA revealed that extinction occurred
in the Sham+Saline 24 h group across the multiple extinctions tests
(F4,54 = 10.872, P < 0.001). Post-hoc analysis showed significant
differences in the percentage of freezing time between the extinction 1
with the extinction 3 (P < 0.05), and extinctions 4–5 (both,
P < 0.01), and the extinction 2 and the extinction 5 (P < 0.01) and
the extinction 3 and extinction 5 (P < 0.05) (Fig. 3D).
Extinction index data are shown in Fig. 3E. A two-way ANOVA
analysis demonstrated main significant effects of SPS (F1,149 = 63.997,
P < 0.001) and treatment (F7,149 = 5.665, P < 0.001) and an inter-
action between SPS and treatment (F7,149 = 8.415, P < 0.001). Post
hoc analysis demonstrated that the percentage of extinction was sig-
nificantly higher in the Sham+Saline 0 h than SPS+ Saline 0 h
(P < 0.01), Sham+Saline 6 h than SPS+ Saline 6 h (P < 0.01),
Sham+Saline 12 h than SPS+ Saline 12 h (P < 0.001) and Sham+
Saline 24 h than SPS+ Saline 24 h groups (P < 0.001). The percentage
of extinction was significantly higher in the SPS+Morphine 6 h than
SPS+ Saline 6 h (P < 0.05), SPS+Morphine 12 h than SPS+ Saline
12 h (P < 0.01) and SPS+Morphine 24 h than SPS+ Saline 24 h
(P < 0.001) groups.
These findings together that SPS impaired contextual fear extinction
and morphine administration 24 h after SPS had a protective effect
against SPS-induced impairment in fear extinction.
Fig. 4A showed the effects of naloxone pretreatment on morphine
influences on extinction response in SPS rats. Data of SPS+ Saline 24 h
and SPS+Morphine 24 h groups from previous experiment were in-
cluded in this analysis. A two-way repeated measure ANOVA analysis
revealed main significant effects of extinction (F4,152 = 59.862,
P < 0.001) and treatment (F3,38 = 23.216, P < 0.001), an interaction
between extinctions and treatment (F12,152 = 7.686, P < 0.001). Post
hoc analysis indicated that the percentage of freezing time of the
SPS+Morphine 24 h group was significantly lower than the SPS+
Saline 24 h in the extinction 2 (P < 0.01), extinction 3 (P < 0.001),
extinction 4 (P < 0.001) and extinction 5 (P < 0.01). The percentage
of freezing time of the SPS+Naloxone+Morphine 24 h group was
significantly higher than the SPS+Morphine 24 h in the extinction 2
(P < 0.01), extinction 3 (P < 0.001), extinction 4 (P < 0.001) and
extinction 5 (P < 0.01).
Extinction index data are shown in Fig. 4B. A one-way ANOVA
analysis showed significant differences among groups (F3,36= 16.192,
P < 0.001). Post hoc analysis indicated that the percentage of extinc-
tion was significantly higher in the SPS+Morphine 24 h than the
SPS+ Saline 24 h (P < 0.001), but it was significantly lower in the
SPS+Naloxone+Morphine 24 h (P < 0.01) than the SPS+
Morphine 24 h (P < 0.001).
These findings indicate that the protective effects of morphine
against SPS - induced fear extinction deficits are mediated through via
opioid receptors.
3.3. Morphological analysis
Data of dendritic length of neurons in the IL are shown in Fig. 5A. A
two-way ANOVA analysis on dendritic length of neurons showed main
significant effects of SPS (F1,80 = 365.3307, P < 0.001) and treatment
(F7,80 = 760.6946, P < 0.001). Furthermore, a significant interaction
between SPS and treatment (F7,80 = 133.888, P < 0.001) was shown.
Post hoc analysis showed that dendritic length of the IL pyramidal
neurons was significantly decreased in the SPS+ Saline 0 h than the
Sham+SAL 0 h (P < 0.001), SPS+ Saline 6 h than the Sham+SAL
6 h (P < 0.001), SPS+ Saline 12 h than the Sham+SAL 12 h
(P < 0.001) and SPS+ Saline 24 h than the Sham+SAL 24 h
(P < 0.001). Dendritic length of the IL neurons increased in the
SPS+Morphine 0 h than the SPS+ SAL 0 h (P < 0.001), SPS+
Morphine 6 h than the SPS+ SAL 6 h (P < 0.001), SPS+Morphine
12 h than the SPS+ SAL 12 h (P < 0.001) and SPS+Morphine 24 h
than the SPS+ SAL 24 h (P < 0.001). The same effect was shown
between the Sham+Morphine 0 h than the Sham+SAL 0 h
(P < 0.001), Sham+Morphine 6 h than the Sham+SAL 6 h
(P < 0.001), Sham+Morphine 12 h than the Sham+SAL 12 h
(P < 0.001) and Sham+Morphine 24 h than the Sham+SAL 24 h
(P < 0.001).
Data from dendritic spines of the IL neurons are shown in Fig. 5B. A
two-way ANOVA analysis on dendritic spines showed main significant
effects of SPS (F1,80 = 110.360, P < 0.001), treatment (F7,80 =
84.479, P < 0.001) and a significant interaction between SPS and
treatment (F7,80 = 2.561, P < 0.05). Post hoc analysis showed that
dendritic spines of the IL neurons were significantly decreased the
SPS+ Saline 0 h than the Sham+SAL 0 h (P < 0.001), SPS+ Saline
6 h than the Sham+SAL 6 h (P < 0.01), SPS+ Saline 12 h than the
Fig. 4. Naloxone pretreatment blocks morphine effects on fear extinction in SPS
rats. (A); a: P < 0.01, b: P < 0.001, c: P < 0.001 and d: P < 0.001 com-
pared with the SPS+ Saline animals. e: P < 0.01, f: P < 0.001, g: P < 0.001
and h: P < 0.001 compared with the SPS+Morphine 24 h group. (B);
Extinction index; a: P < 0.001 compared with the SPS+ Saline 24 h group, b:
P < 0.001 compared with the SPS+Morphine 24 h group. Data represent the
mean ± SEM. SAL: Saline, MOR: Morphine, NAL: Naloxone; SPS: Single pro-
longed stress.
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Sham+SAL 12 h (P < 0.05), SPS+ Saline 24 h than the Sham+SAL
24 h (P < 0.05). Moreover, dendritic length of the IL neurons in-
creased in the SPS+Morphine 0 h than the SPS+ SAL 0 h
(P < 0.001), SPS+Morphine 6 h than the SPS+ SAL 6 h
(P < 0.001), SPS+Morphine 12 h than the SPS+ SAL 12 h
(P < 0.001) and SPS+Morphine 24 h than the SPS+ SAL 24 h
(P < 0.001). The same effect was shown between the Sham+
Morphine 6 h than the Sham+SAL 6 h (P < 0.001), Sham+
Morphine 12 h than the Sham+SAL 12 h (P < 0.001) and Sham+
Morphine 24 h than the Sham+SAL 24 h (P < 0.001). Representative
camera lucida drawings of Golgi-impregnated PL pyramidal neurons
from control, SPS+ saline and SPS+morphine rats are depicted in
Fig. 5C.
Data from dendritic length of neurons in the PL are shown in
Fig. 6A. A two-way ANOVA showed main significant effects of SPS
(F1,80 = 477.267, P < 0.001) and treatment (F7,80 = 134.5304,
P < 0.001). Moreover, a significant interaction between SPS and
treatment (F7,80 = 65.210, P < 0.001) was shown. Between groups
comparisons revealed the dendritic length of the PL neurons was in-
creased in the SPS+Morphine 0 h than the SPS+ SAL 0 h
(P < 0.001), SPS+Morphine 6 h than the SPS+ SAL 6 h
(P < 0.001), SPS+Morphine 12 h than the SPS+ SAL 12 h
(P < 0.001) and SPS+Morphine 24 h than the SPS+ SAL 24 h
(P < 0.001). The same effect was found between the Sham+
Morphine 0 h than the Sham+SAL 0 h (P < 0.001), Sham+
Morphine 6 h than the Sham+SAL 6 h (P < 0.001), Sham+
Morphine 12 h than the Sham+SAL 12 h (P < 0.001) and Sham+
Morphine 24 h than the Sham+SAL 24 h (P < 0.001).
Data from dendritic spines of neurons in the PL are shown in Fig. 6B.
A two-way ANOVA showed main significant effects of SPS (F1,80 =
134.140, P < 0.001) and treatment (F7,80 = 77.618, P < 0.001).
Also, a significant interaction between SPS and treatment
(F7,80= 2.996, P < 0.01) was seen. Post hoc analysis showed that
dendritic spines of neurons were significantly decreased in the SPS+
Saline 0 h than the Sham+SAL 0 h (P < 0.001), SPS+ Saline 6 h than
the Sham+SAL 6 h (P < 0.001), SPS+ Saline 12 h than the
Sham+SAL 12 h (P < 0.001), and SPS+ Saline 24 h than the
Sham+SAL 24 h (P < 0.05). Moreover, dendritic spines of neurons in
the PL was increased in the SPS+Morphine 0 h than the SPS+ SAL 0 h
(P < 0.01), SPS+Morphine 6 h than the SPS+ SAL 6 h (P < 0.001),
SPS+Morphine 12 h than the SPS+ SAL 12 h (P < 0.001) and
SPS+Morphine 24 h than the SPS+ SAL 24 h (P < 0.001). The same
effect was shown between the Sham+Morphine 6 h than the
Sham+SAL 6 h (P < 0.01), Sham+Morphine 12 h than the
Sham+SAL 12 h (P < 0.001) and Sham+Morphine 24 h than the
Sham+SAL 24 h (P < 0.001). Representative camera lucida drawings
of Golgi-impregnated PL pyramidal neurons from control, SPS+ saline
and SPS+morphine rats are depicted in Fig. 2 6C.
These data showed that SPS decreased both dendritic length and
spines in the IL and dendritic length in the PL regions of the mPFC.
Morphine injection, particularly 24 h after SPS, significantly blocked
the effect of SPS on dendritic morphology of the pyramidal neurons in
the mPFC.
4. Discussion
The present study investigated the therapeutic effects of morphine
injected at different time points (immediately, 6, 12 and 24 h) after SPS
Fig. 5. Dendritic length and spines of neurons in the infralimbic (IL) of the medial prefrontal cortex in sham and SPS rats in the presence and absence of morphine.
(A); Dendritic length of neurons in the IL; a: P < 0.001 than the Sham+SAL 0 h group, b: P < 0.001 than the Sham+SAL 6 h group c: P < 0.001 than the
Sham+SAL 12 h group and d: P < 0.001 than the Sham+SAL 24 h group, e: P < 0.001 than the SPS+ SAL 0 h group, f: P < 0.001 than the SPS+ SAL 6 h
group, g: P < 0.001 than the SPS+ SAL 12 h, h: P < 0.001 than the SPS+ SAL 24 h group, i: P < 0.001 than the Sham+SAL 0 h group, j: P < 0.001 than the
Sham+SAL 6 h group, k: P < 0.001 than the Sham+SAL 12 h group and l: P < 0.001 than the Sham+SAL 24 h group. (B); Dendritic spines of neurons in the IL
a: P < 0.001 than the Sham+SAL 0 h group, b: P < 0.01 than the Sham+SAL 6 h group, c: P < 0.05 than the Sham+SAL 12 h group, d: P < 0.05 than the
Sham+SAL 24 h group, e: P < 0.001 than the SPS+ SAL 0 h group, f: P < 0.001 than the SPS+ SAL 6 h group, g: P < 0.001 than the SPS+ SAL 12 h group, h:
P < 0.001 than the SPS+ SAL 24 h group, i: P < 0.001 than the Sham+Saline 6 h, j: P < 0.001 than the Sham+Saline 12 h and k: P < 0.001 than the
Sham+Saline 24 h. C; Camera lucida drawings of representative Golgi-impregnated IL pyramidal neurons from control, SPS+ saline, and SPS+morphine rats.
SAL: Saline, MOR: Morphine, SPS: Single prolonged stress.
P. RaiseAbdullahi, et al. Behavioural Brain Research 364 (2019) 19–28
24
as an experimental model of PTSD in adult male rats. We found that the
saline-treated SPS rats showed enhanced anxiety-like behaviors, im-
paired fear extinction, and dendritic retraction in the mPFC. Morphine
injection particularly 24 h after the SPS selectively reversed the SPS-
induced deficits in anxiety profile, fear extinction, and dendritic mor-
phology in the mPFC. Taken together, it is reasonable to conclude that
morphine had a protective and therapeutic effect on SPS rats.
4.1. SPS impairs contextual fear extinction and increases anxiety-like
behaviors: Beneficial effects of morphine
In terms of the fear extinction, predictably, all groups had a similar
and high percentage of freezing time in the early extinction tests, be-
cause during training, conditioned stimulus (CS) was paired to noxious
unconditioned stimulus (US) in all animals. As a result, the percentage
of freezing time was high on the first and/or second days after training.
But after a while, the CSeUS connection was gradually unpaired in the
sham groups which represents unimpaired fear extinction in control
animals. Consequently, the percentage of freezing time of the control
groups dropped with a steep slope during following the remaining ex-
tinction tests of the experiment. On the contrary, the percentage of
freezing time did not decrease in the saline-treated SPS groups even
until the last day of the experiment. In addition, the extinction index of
the saline-treated SPS animals was significantly lower than the sham
groups. These findings show the impairment of fear extinction in SPS
rats, and are in line with previous studies reporting that SPS impairs
contextual fear conditioning [46]. In agreement with the previous
findings, anxiety-like behaviors significantly increased in the saline-
treated SPS rats than the sham groups [47]. Morphine-treated SPS an-
imals showed an increased percentage of open arm time and entry
compared with the saline-treated SPS groups. Morphine-treated SPS
rats showed an extinction curve with a slope like the sham animals.
Interestingly, the protective effect of morphine was time-dependent,
and the most impressive effect of morphine was seen when injected
24 h after SPS. Our findings confirm the results of a recent study
showing that a single dose of morphine reduces stress-enhanced fear
learning (an animal model of the PTSD) when administrated 48 h after
the severe stressor [20]. The observed time-dependent effect of mor-
phine against SPS induced impairments in fear extinction is interesting
and strange. Some clinical studies were mentioned earlier suggested
that one interpretation of the protective effect of morphine on PTSD is
probably due to analgesic effect of morphine and decreased in the pain
experience [12,48]. If that was the case, why the present study did not
show the most impressive effect of morphine immediately after the SPS
that the analgesic effect of morphine would most be potent? The pro-
tective effect of morphine almost was not seen in the SPS+morphine
0 h group and was much weaker in the SPS+morphine 6 h group than
the SPS+morphine 12 h and SPS+morphine 24 h group. In addition,
morphine effect was weaker in the SPS+morphine 12 h than the
SPS+morphine 24 h group. Finally, the protective effect of morphine
was disappeared when naloxone was injected 30min prior to morphine.
Thus, it is reasonable to conclude that the protective effect of morphine
might be mediated via its opioid receptors [19,49].
The mechanisms underlying the protective effects of morphine are
not known. We found that the protective effect of morphine against SPS
appeared when morphine was injected from 6 h after the SPS.
Interestingly, the protective effect of morphine was stronger and ap-
peared sooner when morphine was injected 24 h after the SPS.
Importantly, morphine half-life is about 2–4 h. Moreover, it takes, at
least, 7–14 days to develop the SPS symptoms [30]. So the question is
how does morphine do this protective effect on the SPS animals? It is
more likely that morphine targeted the early biochemical, cellular and
neural mechanisms critical for PTSD development in the later. One
important process is memory consolidation during which the gene ex-
pression and protein synthesis work in parallel pathways to consolidate
the traumatic information experienced during the SPS. Morphine may
Fig. 6. Dendritic length and spines of neurons in the prelimbic (PL) of the medial prefrontal cortex in sham and SPS rats in the presence and absence of morphine..
(A); Dendritic length of neurons in the PL; a: P < 0.001 than the SPS+ SAL0 h group, b: P < 0.001 than the SPS+ SAL 6 h, c: P < 0.001 than the SPS+ SAL 12 h
and d: P < 0.001 than the SPS+ SAL 24 h e: P < 0.001 than the Sham+SAL 0 h group, f: P < 0.001 than the Sham+SAL 6 h, g: P < 0.001 than the
Sham+SAL 12 h and h: P < 0.001 than the Sham+SAL 24 h.(B); Dendritic spines of neurons in the PL; a: P < 0.001 than the Sham+SAL 0 h, b: P < 0.001 than
the Sham+SAL 6 h, c: P < 0.001 than the Sham+SAL 12 h, d: P < 0.001 than the Sham+SAL 24 h, e: P < 0.001 than the SPS+ SAL 0 h, f: P < 0.001 than the
SPS+ SAL 6 h, g: P < 0.001 than the SPS+ SAL 12 h, h: P < 0.001 than the SPS+ SAL 24 h group. i: P < 0.01 than the Sham+Saline 6 h, j: P < 0.001 than the
Sham+Saline 12 h and k: P < 0.001 than the Sham+Saline 24 h. C; Camera lucida drawings of representative Golgi-impregnated PL pyramidal neurons from
control, SPS+ saline and SPS+morphine rats. SAL: Saline; MOR: Morphine, SPS: Single prolonged stress.
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act via its receptors to inhibit the consolidation process of the traumatic
event [50]. Interestingly, an immediate injection of morphine was not
effective, confirming our assumption that morphine targets the con-
solidation process which starts at least 3–6 h after the traumatic event
and lasts over the next 24 h. 24 h post training is a critical time point in
terms of consolidation process and extinction of the fear memory [51].
But, the question remains, how does morphine affect the brain areas
responsible for fear memory? Plastic events in the amygdala have been
suggested as a key factor in the extinction process [52]. It seems that CS
information projects from basolateral amygdala (BLA) to intercalated
(ITC) amygdala neurons [53,54], which send inhibitory GABAergic
projections to the central amygdala (CeA) [55,56]. ITC has been pro-
posed as the main part in controlling the flow of information between
the BLA and CeA. Regarding conditioned fear responses, CeA is the
main part of the amygdala [57]. The IL sends projections to ITC that
inhibits CeA [58,59] and accelerates extinction [60]. Recent studies
showed an increased responsiveness of the IL neurons after extinction
training [60,61]. Altogether, it would be possible that soon after re-
ceiving a conditioned stimulus, CS-related inputs from the BLA and IL
integrate in ITC neurons. As a result, the GABAergic projection of ITC
dampens the output of the CeA and leads to a reduction of fear re-
sponses. Previous western blot studies showed that morphine increases
expression of the mu receptors in the amygdala. The high amount of the
mu receptors are localized in the ITC [52,62]. Likhtik et al., reported
that ITC lesions caused remarkable deficits in the expression of ex-
tinction [52], so it is reasonable to conclude that morphine stimulates
the mu receptors in the ITC, which increases ITC inhibitory projection
to CeA, culminating a less fear response and freezing. Further studies
are required to test this assumption.
4.2. SPS decreases dendritic length and spines in the mPFC: Beneficial
effects of morphine
We found that SPS and control animals differ in the dendritic ar-
chitecture of mPFC neurons, which form the main part of the neural
circuitry of extinction [63,64]. SPS decreased dendritic length and
spines in the IL area and dendritic length in the PL region, showing that
SPS-induced changes in neuronal morphology of the mPFC are mainly
limited to the IL, but not the PL. This finding is very interesting and is in
line with a previous work [65]. In terms of stress, the IL is the most
sensitive part of the mPFC. Instead, the PL might be more sensitive to
prolonged stress and probably involved with conditioned fear expres-
sion [66]. Surprisingly, Knox et al. reported the high PL neural activity
in all animals including sham rats during extinction testing, since, ex-
cept the SPS animals the levels of conditioned fear were low in the rest
of the rats [67]. Some studies have shown the low PL neural activity
during extinction testing [68], and some others have reported the high
PL activity [69]. The IL sends an inhibitory projection to CeA and plays
a critical role in extinction. In fact, inhibition of the BLA neural activity
by IL is a critical part of extinction [70,71]. Thus, it would be possible
that dendritic retraction of the IL could attenuate IL inhibitory function
on BLA and ITC and contribute to impaired extinction in the SPS rats
that needs further investigation.
Morphologically, our findings show morphine significantly in-
creased dendritic spines in the mPFC in both sham and SPS rats. The
effect of morphine was impressive when injected 24 h after the SPS.
Morphine also increased dendritic length in the IL and PL in both sham
and SPS rats. This effect of morphine was more remarkable when in-
jected immediately after the SPS. These different pattern and time-point
effects of morphine on the dendritic length and spines are very inter-
esting and need to be further explored. Importantly, morphine has
pronounced effects in both sham and stress conditions. Thus, it is not
clear whether the effect of morphine alone is protective against effects
of the SPS or simply has effects that mask the appearance of the stress
effect. In other words, does morphine prevent the effect of stress on
dendrites or provide an effect by itself that masks the appearance of the
stress effect. The explanation of these unanswered questions and the
reason of the time-dependent effects of morphine in both sham and SPS
rats need further carefully designed studies.
The mPFC plays a critical role in the regulation of emotional be-
haviors and fear extinction [70,71]. The present study showed that the
SPS led to dendritic retractions and loss in the mPFC; these changes
appear to be the morphological correlate of SPS - induced impairment
of the mPFC-dependent behavior(s). The present study showed that
morphine administration after the SPS recovered stress induced beha-
vioral deficits and structural abnormalities in the mPFC.
4.3. Possible intracellular pathways of beneficial effects of morphine on SPS
induced behavioral and morphological impairments
Recent studies have reported some new pharmacological ap-
proaches to PTSD treatment including NMDA receptor agonists such as
D-cycloserine and brain-derived neurotrophic factor (BDNF) agonists
[72,73]. Administration of NMDA receptor antagonists impairs extinc-
tion retention showing that NMDA receptors are involved in fear
memory extinction [74,75]. Morphine positively modulates NMDA re-
ceptors. Indeed, the interaction between mu and NMDA receptors is
bidirectional [76]. Chen et al. and Heinricher et al. have reported
sustained glutamate-activated NMDA receptors currents by activation
of mu receptors [77,78]. Morphine may act via NMDA receptors and
change long-term potentiation (LTP). LTP may underlie synaptic plas-
ticity in the hippocampus and amygdala during fear extinction [79,80].
Moreover, BDNF has been reported to be involved in LTP probably
through its interaction with TrkB [81,82]. Morphine elevates BDNF
mRNA in the brain subregions such as locus coeruleus, ventral teg-
mental area, mPFC and amygdala [83–85]. It is reasonable to conclude
that morphine may affect LTP via NMDA and BDNF and the related
intracellular signaling pathways of LTP, leading to increased fear ex-
tinction.
Morphine may act via inflammatory cytokines such as tumor ne-
crosis factor-α (TNF-α) and interleukin-1β (IL-1β) that have been as-
sociated with depression, anxiety and PTSD pathogenesis [86,87].
Transgenic animals with deficient pro-inflammatory cytokines showed
altered anxiety-like behavior in the EPM and open field tests [88,89].
Spivak et al. have reported an elevated level of IL-1β in PTSD patients
[86]. Jones et al. have shown that severe stressor induces IL-1β ex-
pression in the dorsal hippocampus [90]. They have alleged that sys-
temic morphine treatment reduces IL-1β expression in the dorsal hip-
pocampus, one of the brain regions critical for extinction retention
[67]. It is accepted that opioid receptors regulate the development of
fear extinction [50]. Administration of opioid antagonists increase
conditioned fear [91], and, the present study showed that beneficial
effect of morphine on fear extinction of the SPS animals was dis-
appeared when naloxone was injected before morphine. Even micro-
injection of morphine into the amygdala diminished the expression of
fear responses. Opioid signaling in the ventrolateral periaqueductal
gray matter has been proposed to regulating conditioned fear extinction
[92,93]. Conversely, Parsons et al, have emphasized the role of NMDA
but not opioid receptors in the amygdala for fear conditioning extinc-
tion [93]. Miller et al., have reported that the binding of morphine to its
mu receptors time-dependently changes AMPA receptor subunit com-
position and Ca2+ dynamics, which lead to morphine-induced altera-
tion in dendritic spines amount [94]. However, there is a need for more
studies to determine the likely mechanisms by which morphine pre-
vents the development of PTSD.
Briefly, we found that SPS gave rise to more anxiety-like behaviors
and impaired fear extinction in male rats. SPS decreased dendritic
length and spines of neurons in the mPFC. Conversely, morphine ad-
ministration within a restricted time window selectively improved an-
xiety-like behaviors, fear extinction, and increased dendritic length,
and spines in the mPFC. Our findings suggest that the time point of
morphine injection following a traumatic event is an important
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determinant of the full therapeutic effect of morphine against PTSD.
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